Gambia: U.S. Donates 151, 200 Doses of J&J Covid-19 Vaccine to Gambia

The Ministry of Health has on Tuesday 0th July 2021 informed the media that the Government of the United States of America has donated to The Gambia over 150 thousand (151,200) doses of the Johnson & Johnson/Janssen (J&J/Janssen) COVID-19 vaccine to boost the national vaccination campaign currently underway.

With support from the COVAX Facility, the vaccines arrived in the country on Tuesday, 20th July 2021 and were received at Banjul International Airport by officials of the Ministry of Health, other government officials and development partners.

The contribution of the Government of the United States comes at a moment when COVID-19 cases are escalating rapidly in The Gambia as more than 925 positive cases have been confirmed between 23rd June and 16th July.

Since the confirmation of the first COVID-19 case in March 2020, The Gambia has registered a total of 6,920 cases and 190 deaths.

"President Joe Biden committed that the United States will be an "arsenal for vaccines" and we are pleased to partner with the African Union, COVAX, WHO, and UNICEF to support the Gambia government's vaccination efforts led by the Ministry of Health. This initial delivery from the U.S. contribution of over 304,000 doses of the single-dose Johnson & Johnson vaccine - on top of $2 billion provided by the United States to COVAX in April to buy vaccines for the world - is only the beginning. We will continue to donate surplus vaccine supply, as it is available to us, and we will soon begin delivering on our contribution of 500 million Pfizer doses for distribution by COVAX to countries around the world, including The Gambia. Only by working together - and by getting vaccinated! - can we combat and end the COVID pandemic," said H.E Richard Carlton Paschall III, U.S. Ambassador to The Gambia.

The J&J COVID-19 vaccine has been approved by the World Health Organization under the Emergency Use Listing (EUL) as well as by the Gambia Medicines Control Agency.

Officials from the health ministry said the donation will significantly close the gap towards achieving the national target of vaccinating 60% of the population by June 2022.

In order to urgently scale up the COVID-19 vaccination program, the health ministry will immediately introduce the J&J/Janssen vaccine into the nationwide campaign which is currently underway and implemented in communities and health facilities across the country, as well as in different strategic locations such as "bantabas", points of entry and other identified areas.

Gordon Jonathan Lewis, UNICEF Representative, said "this generous contribution of shared vaccines from the Government of the United States will go a long way towards achieving vaccine equity in The Gambia and will ensure that we can vaccinate a larger number of individuals in a shorter period of time, especially now that new cases are rapidly rising. Getting vaccinated is the right thing to do, getting vaccinated is the ethical thing to do."

Dr Desta Tiruneh, WHO Representative, added that: "WHO welcomes the substantial contribution of vaccines from the Government of the United States through COVAX at a time when The Gambia is witnessing a significant spike in the number of COVID19 cases. Global vaccine sharing is the only way we can vaccinate at least 10% of the population of every country by the end of September 2021."

In receiving the contribution, Minister of Health Dr. Ahmadou Lamin Samateh, noted that The Gambia is currently witnessing its third wave of the epidemic and therefore the donation could not have come at a better time.

"These vaccines will not only complement our national vaccination program but also strengthen overall preventive public health measures," he said.

AllAfrica publishes around 800 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

X